Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CNO | TSXV | CAD | Delayed | |
CNO | CBOE Canada | CAD | Real-time |
For the nine months ended 30 November 2021, California Nanotechnologies Corp revenues decreased 6% to $609K. Net loss decreased 38% to $52K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Office decrease of 43% to $38K (expense), Consulting decrease of 88% to $2K (expense), Other Income/(expense) increase from $0K to $15K (income).
Period Ending: | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
---|---|---|---|---|
Total Revenue | 0.23 | 0.17 | 0.21 | 0.15 |
Gross Profit | 0.16 | 0.11 | 0.13 | 0.1 |
Operating Income | -0.01 | -0.02 | 0.01 | -0.08 |
Net Income | -0.02 | -0.02 | -0.01 | -0.04 |
Period Ending: | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
---|---|---|---|---|
Total Assets | 0.43 | 0.44 | 0.52 | 0.46 |
Total Liabilities | 1.76 | 1.77 | 1.83 | 1.77 |
Total Equity | -1.33 | -1.34 | -1.32 | -1.31 |
Period Ending: | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 0.01 | 0.01 | -0.01 | 0.02 |
Cash From Investing Activities | -0.01 | -0.01 | 0 | |
Cash From Financing Activities | 0 | 0.01 | 0.04 | -0.05 |
Net Change in Cash | 0.01 | 0 | 0.04 | -0.02 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review